⁣iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
28:07
⁣iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
VJHemOnc Podcast
1 Tampilan · 09/22/23
⁣Real-world CAR T therapy in older DLBCL patients, monoclonal antibody blocking APC for hemophilia therapy, and targeting the epichaperome in AML
18:14
⁣Real-world CAR T therapy in older DLBCL patients, monoclonal antibody blocking APC for hemophilia therapy, and targeting the epichaperome in AML
Blood Podcast
2 Tampilan · 09/21/23
⁣iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
18:05
⁣iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
VJHemOnc Podcast
0 Tampilan · 09/15/23
⁣Karlijn Jeuring- AML binnen een missiegedreven bank
38:28
⁣Karlijn Jeuring- AML binnen een missiegedreven bank
Compliance Adviseert: ervaringen van experts uit de Nederlandse financiële sector
1 Tampilan · 09/11/23
⁣Ep. 64: Olivier Roland on Escaping the Tyranny of Place, History Lessons About Technical Disruption for the Internet Age and the Staggering Ineffectiveness of AML-KYC
01:08:20
⁣Ep. 64: Olivier Roland on Escaping the Tyranny of Place, History Lessons About Technical Disruption for the Internet Age and the Staggering Ineffectiveness of AML-KYC
Stranded Technologies Podcast
0 Tampilan · 09/05/23
⁣FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
10:45
⁣FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
OncLive® On Air
1 Tampilan · 08/21/23
⁣Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
13:41
⁣Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
OncLive® On Air
0 Tampilan · 08/14/23
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
30:34
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
PeerView Clinical Pharmacology CME/CNE/CPE Video
0 Tampilan · 08/11/23
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
30:30
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
0 Tampilan · 08/11/23
⁣Silent infarcts in iTTP remission, a ZDHHC palmitoyltransferase regulates oxidative phosphorylation in AML, and hepatic sinusoid as a niche for ANKL
18:41
⁣Silent infarcts in iTTP remission, a ZDHHC palmitoyltransferase regulates oxidative phosphorylation in AML, and hepatic sinusoid as a niche for ANKL
Blood Podcast
1 Tampilan · 07/27/23
⁣The Convergence of ABC, AML and Export Controls with Mike Huneke and Jan Dunin-Wasowicz
29:53
⁣The Convergence of ABC, AML and Export Controls with Mike Huneke and Jan Dunin-Wasowicz
All Things Investigations
0 Tampilan · 07/10/23
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
01:16:34
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
PeerView Clinical Pharmacology CME/CNE/CPE Video
0 Tampilan · 07/06/23
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
01:16:27
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
0 Tampilan · 07/06/23
⁣VIP AUDIO 6/29 – PWTorch Dailycast – Wrestling Coast to Coast (AD-FREE): Maitland & McClelland review AML Wrestling Confrontation including Bailey vs. Brash, Ray vs. Attitude, Fatu vs. Bojack, more (84 min.)
01:24:26
⁣VIP AUDIO 6/29 – PWTorch Dailycast – Wrestling Coast to Coast (AD-FREE): Maitland & McClelland review AML Wrestling Confrontation including Bailey vs. Brash, Ray vs. Attitude, Fatu vs. Bojack, more (84 min.)
Wrestling Coast to Coast
1 Tampilan · 06/29/23
⁣Key role of hepcidin in polycythemia vera, signatures of CAR T cell dysfunction, and IL-34 as a novel AML therapy?
19:26
⁣Key role of hepcidin in polycythemia vera, signatures of CAR T cell dysfunction, and IL-34 as a novel AML therapy?
Blood Podcast
1 Tampilan · 06/29/23
⁣Stephen Carter, AML Smith-Pettit Foundation Award
54:13
⁣Stephen Carter, AML Smith-Pettit Foundation Award
The Dialogue Journal
0 Tampilan · 06/09/23
⁣The Ticking Time bomb of AML Compliance I Avalanche Summit II
30:19
⁣The Ticking Time bomb of AML Compliance I Avalanche Summit II
The AVAX Podcast
0 Tampilan · 06/07/23
⁣#4- Interview with Erica Brackman (Product Marketing Manager (AML), NICE Actimize)
17:46
⁣#4- Interview with Erica Brackman (Product Marketing Manager (AML), NICE Actimize)
The B2B Messaging Podcast by Wynter
0 Tampilan · 06/06/23
⁣Webinar - Keeping Up with the ID Criminals (AML and fraud detection technologies)
01:15:38
⁣Webinar - Keeping Up with the ID Criminals (AML and fraud detection technologies)
Lands of Milk and Honey
0 Tampilan · 12/02/22
⁣The Sunday Roast 13th November 2022 weekly roundup #GGP #BEN #KIBO #AFP #GLR #GRIT #SPEC #EST #MILA #AML #Copper #Gold #Oil #CHLL #PRD #HARL #MAST#ARV #ADME #PXEN #XTR #JLP #ARV
32:10
⁣The Sunday Roast 13th November 2022 weekly roundup #GGP #BEN #KIBO #AFP #GLR #GRIT #SPEC #EST #MILA #AML #Copper #Gold #Oil #CHLL #PRD #HARL #MAST#ARV #ADME #PXEN #XTR #JLP #ARV
The Sunday Roast
1 Tampilan · 11/13/22

AML

0 Tampilan· 09/22/23
Tumor Talks
Tumor Talks
0 Pelanggan
0
Di

Learn about the epidemiology, diagnostics and other basics of AML with Dr. Jonathan Webster

Menampilkan lebih banyak
 0 Komentar sort   Sortir dengan


Berikutnya


⁣iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
28:07
⁣iwAL 2023 Session II: Novel treatments in AML: FLT3 inhibitors, combinations, and more
VJHemOnc Podcast
1 Tampilan · 09/22/23
⁣Real-world CAR T therapy in older DLBCL patients, monoclonal antibody blocking APC for hemophilia therapy, and targeting the epichaperome in AML
18:14
⁣Real-world CAR T therapy in older DLBCL patients, monoclonal antibody blocking APC for hemophilia therapy, and targeting the epichaperome in AML
Blood Podcast
2 Tampilan · 09/21/23
⁣iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
18:05
⁣iwAL 2023 Session I: Clonal hematopoiesis in AML, early detection and potential therapeutics
VJHemOnc Podcast
0 Tampilan · 09/15/23
⁣Karlijn Jeuring- AML binnen een missiegedreven bank
38:28
⁣Karlijn Jeuring- AML binnen een missiegedreven bank
Compliance Adviseert: ervaringen van experts uit de Nederlandse financiële sector
1 Tampilan · 09/11/23
⁣Ep. 64: Olivier Roland on Escaping the Tyranny of Place, History Lessons About Technical Disruption for the Internet Age and the Staggering Ineffectiveness of AML-KYC
01:08:20
⁣Ep. 64: Olivier Roland on Escaping the Tyranny of Place, History Lessons About Technical Disruption for the Internet Age and the Staggering Ineffectiveness of AML-KYC
Stranded Technologies Podcast
0 Tampilan · 09/05/23
⁣FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
10:45
⁣FDA Approval Insights: Quizartinib in Newly Diagnosed, FLT3-ITD+ AML
OncLive® On Air
1 Tampilan · 08/21/23
⁣Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
13:41
⁣Bhatnagar Spotlights Ongoing Uproleselan Investigations in AML
OncLive® On Air
0 Tampilan · 08/14/23
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
30:34
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
PeerView Clinical Pharmacology CME/CNE/CPE Video
0 Tampilan · 08/11/23
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
30:30
⁣Mark J. Levis, MD, PhD - Finding the Key to Better Outcomes in FLT3-Mutated AML: Guidance on New Evidence With Next-Gen FLT3 Inhibitors
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
0 Tampilan · 08/11/23
⁣Silent infarcts in iTTP remission, a ZDHHC palmitoyltransferase regulates oxidative phosphorylation in AML, and hepatic sinusoid as a niche for ANKL
18:41
⁣Silent infarcts in iTTP remission, a ZDHHC palmitoyltransferase regulates oxidative phosphorylation in AML, and hepatic sinusoid as a niche for ANKL
Blood Podcast
1 Tampilan · 07/27/23
⁣The Convergence of ABC, AML and Export Controls with Mike Huneke and Jan Dunin-Wasowicz
29:53
⁣The Convergence of ABC, AML and Export Controls with Mike Huneke and Jan Dunin-Wasowicz
All Things Investigations
0 Tampilan · 07/10/23
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
01:16:34
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
PeerView Clinical Pharmacology CME/CNE/CPE Video
0 Tampilan · 07/06/23
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
01:16:27
⁣Naval Daver, MD - Pushing Innovation in AML: Real-World Integration of Modern Therapeutics Into Personalized Patient Management
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
0 Tampilan · 07/06/23
⁣VIP AUDIO 6/29 – PWTorch Dailycast – Wrestling Coast to Coast (AD-FREE): Maitland & McClelland review AML Wrestling Confrontation including Bailey vs. Brash, Ray vs. Attitude, Fatu vs. Bojack, more (84 min.)
01:24:26
⁣VIP AUDIO 6/29 – PWTorch Dailycast – Wrestling Coast to Coast (AD-FREE): Maitland & McClelland review AML Wrestling Confrontation including Bailey vs. Brash, Ray vs. Attitude, Fatu vs. Bojack, more (84 min.)
Wrestling Coast to Coast
1 Tampilan · 06/29/23
⁣Key role of hepcidin in polycythemia vera, signatures of CAR T cell dysfunction, and IL-34 as a novel AML therapy?
19:26
⁣Key role of hepcidin in polycythemia vera, signatures of CAR T cell dysfunction, and IL-34 as a novel AML therapy?
Blood Podcast
1 Tampilan · 06/29/23
⁣Stephen Carter, AML Smith-Pettit Foundation Award
54:13
⁣Stephen Carter, AML Smith-Pettit Foundation Award
The Dialogue Journal
0 Tampilan · 06/09/23
⁣The Ticking Time bomb of AML Compliance I Avalanche Summit II
30:19
⁣The Ticking Time bomb of AML Compliance I Avalanche Summit II
The AVAX Podcast
0 Tampilan · 06/07/23
⁣#4- Interview with Erica Brackman (Product Marketing Manager (AML), NICE Actimize)
17:46
⁣#4- Interview with Erica Brackman (Product Marketing Manager (AML), NICE Actimize)
The B2B Messaging Podcast by Wynter
0 Tampilan · 06/06/23
⁣Webinar - Keeping Up with the ID Criminals (AML and fraud detection technologies)
01:15:38
⁣Webinar - Keeping Up with the ID Criminals (AML and fraud detection technologies)
Lands of Milk and Honey
0 Tampilan · 12/02/22
⁣The Sunday Roast 13th November 2022 weekly roundup #GGP #BEN #KIBO #AFP #GLR #GRIT #SPEC #EST #MILA #AML #Copper #Gold #Oil #CHLL #PRD #HARL #MAST#ARV #ADME #PXEN #XTR #JLP #ARV
32:10
⁣The Sunday Roast 13th November 2022 weekly roundup #GGP #BEN #KIBO #AFP #GLR #GRIT #SPEC #EST #MILA #AML #Copper #Gold #Oil #CHLL #PRD #HARL #MAST#ARV #ADME #PXEN #XTR #JLP #ARV
The Sunday Roast
1 Tampilan · 11/13/22